<DOC>
	<DOCNO>NCT01023711</DOCNO>
	<brief_summary>The purpose study describe immune response novel H1N1 influenza vaccination healthy adult , understand factor allow healthy adult respond single dose vaccine even never previously experience novel H1N1 disease vaccination .</brief_summary>
	<brief_title>Immunologic Response Inactivated Vaccine Novel H1N1 Virus</brief_title>
	<detailed_description>Studies determine single dose inactivate vaccine need immunization novel H1N1 , reason adults appear ready respond single dose know .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 1832 year , 60 year old No history Novel H1N1 virus vaccine Female able bear child pregnant agree practice effective birth control Female negative pregnancy test Good Health Ability understand comply protocol Provided Informed Consent Previous history vaccination novel H1N1 laboratory document H1N1 infection Previous history vaccination A/New Jersey/76 vaccine ( subject 60 &amp; old History egg allergy allergic component vaccine Women pregnant breastfeed intend get pregnant study period enrollment &amp; 30 day follow vaccination Subject immunosuppressed result underlie illness treatment immunosuppressive cytotoxic drug use chemotherapy/radiation therapy precede 36 month Subject active neoplastic disease ( exclude nonmelanoma skin cancer prostate cancer stable absence therapy ) history hematological malignancy . `` Active '' define treatment within past 5 year . Long term ( great 2 week ) use oral parental steroid , high dose inhale steroid ( &gt; 800 mcg/day beclomethasone dipropionate equivalent ) within precede 6 month ( nasal &amp; topical steroid allow ) Received immunoglobulin blood product within 3 month prior enrollment study Subject receive inactivated vaccine within 2 week live vaccine within 4 week prior enrollment plan receive another vaccine within next 28 day Subject acute chronic medical condition , opinion investigator , would render vaccination unsafe would interfere evaluation response . Those condition include chronic condition recognize risk factor influenza complication contraindicate live vaccination , include chronic cardiac ( exclusive hypertension ) pulmonary condition ( include asthma ) , diabetes mellitus , renal impairment Subject acute illness oral temperature great 99.9 F ( 37.7 C ) within 3 day enrollment vaccination . Subject acute illness treat , symptom resolve eligible enroll long treatment complete &amp; symptom resolve &gt; 3 day prior enrollment . Subject currently participate plan participate study involve experimental agent ( vaccine , drug , biologic , device , blood product , medication ) receive experimental agent within 1 month enrollment study , intend donate blood period . Subject condition would , opinion investigator , place subject unacceptable risk injury render subject unable meet requirement protocol Subject diagnosis schizophrenia , bipolar disease , severe ( disable ) chronic psychiatric diagnosis , receive psychiatric drug . Subjects receive single antidepressant drug &amp; stable least 3 month prior enrollment without decompensation allow enrollment study . Subject history alcohol drug abuse 5 year enrollment . Subject know human immunodeficiency virus , hepatitis B , hepatitis C infection . Subject previous history GuillainBarre syndrome within 6 week receipt influenza vaccine Subject condition principal investigator ( PI ) believe may interfere successful completion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Influenza</keyword>
</DOC>